DRUG BRIGHT MINDS BIOSCIENCES INC.
company
SEC Filings & Insider Trading Activity 2026

CIK: 1827401
Health Care
Pharmaceutical Preparations 15 filings
Russell 2000
SC 13G: 6
20-F: 4
6-K: 4
SC 13D: 1

Go deeper on BRIGHT MINDS BIOSCIENCES INC.

Ask AI about DRUG filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.

Track institutional money. See which funds are building or cutting DRUG positions, quarter over quarter.

Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on DRUG.

See Pro plans →

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
6-K
Jun 3, 2026--
6-K
Jun 2, 2026--
6-K
May 28, 2026--
6-K
May 20, 2026--
20-F
Dec 31, 2024Sep 30, 2024-
SC 13G
Nov 12, 2024--
SC 13G
Oct 25, 2024--
SC 13G
Oct 23, 2024--
SC 13G
Oct 23, 2024--
SC 13G
Oct 22, 2024--
SC 13G
Oct 16, 2024--
SC 13D
Jan 18, 2024--
20-F
Dec 29, 2023Sep 30, 2023-
20-F
Dec 29, 2022Sep 30, 2022-
20-F
Dec 29, 2021Sep 30, 2021-

13F Fund Holdings: Quarterly Trend

Latest: Q1 2026

Aggregate DRUG share value held by 13F filers tracked by SignalX, by quarter.

Position changes: Q4 2025 → Q1 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 66 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.

Related Health Care Companies

Browse all Health Care companies →

Frequently Asked Questions

Where can I find DRUG insider trading activity (Form 4)?

SignalX aggregates every DRUG Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does DRUG file with the SEC?

BRIGHT MINDS BIOSCIENCES INC. (DRUG) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new DRUG filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for BRIGHT MINDS BIOSCIENCES INC. (DRUG).

What is DRUG's SEC CIK number?

BRIGHT MINDS BIOSCIENCES INC. (DRUG)'s SEC CIK (Central Index Key) number is 1827401. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1827401 to look up all DRUG filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Stay on top of BRIGHT MINDS BIOSCIENCES INC. SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 15+ filings.